Health X Platform Limited Submits Revised CA Certificate for Name Change Approval

2 min read     Updated on 25 Apr 2026, 06:38 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Health X Platform Limited, formerly known as Sastasundar Ventures Limited, has submitted a revised Chartered Accountants' certificate to BSE and NSE in support of its application to change the company name. The exchanges had requested a bifurcation of revenue to verify compliance with Regulation 45 of SEBI (LODR) Regulations, 2015. The statutory auditors' certificate confirms that more than fifty percent of the company's consolidated revenue is derived from healthcare activity, which aligns with the proposed new name. The company will send the revised certificate to shareholders at the next available opportunity through the Notice of General Meeting or other specified modes under the Companies Act, 2013.

powered bylight_fuzz_icon
38624880

*this image is generated using AI for illustrative purposes only.

Health X Platform Limited, formerly known as sastasundar ventures , has submitted a revised Chartered Accountants' certificate to BSE Limited and National Stock Exchange of India Limited in support of its application for changing the company name from "Sastasundar Ventures Limited" to "Health X Platform Limited." The intimation was made under Regulation 30 of the SEBI (Listing of Obligations and Disclosure Requirements) Regulations, 2015, dated 24-04-2026.

Regulatory Compliance

The stock exchanges had requested the company to furnish a bifurcation of revenue in the CA certificate to affirm compliance with conditions prescribed in Regulation 45 of the SEBI (LODR) Regulations, 2015. The revised certificate, issued by J K V S & Co., Chartered Accountants, confirms that the company has not changed its name in the preceding one-year period, satisfying Regulation 45(1)(a).

Revenue Bifurcation Details

The auditors certified that more than fifty percent of the total revenue of the company, on a consolidated basis, is through the activity suggested by the new name. The detailed bifurcation of revenue for the period from 1st January, 2025 to 31st December, 2025 is as follows:

From 1st January, 2025 to 31st December, 2025 Amount (Rs. in lakhs)
Revenue from business activity - Healthcare Activity 1,20,971.84
Revenue from business activity - Financial Services activity 2,160.79
Total 1,23,132.63

The figures for the period have been taken from the limited review financial results filed by the company with the stock exchanges. Healthcare activity revenue constitutes approximately 98.25% of the total consolidated revenue.

Shareholder Communication

The original certificate was attached to the Postal Ballot Notice dated January 7, 2026, which was sent to the stock exchanges and dispatched to shareholders on January 13, 2026. The company will send the revised CA certificate to shareholders at the next available opportunity, either through the Notice of General Meeting or such other mode as specified in the Companies Act, 2013 read with SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015.

The statutory auditors' certificate was issued on April 9, 2026, by J K V S & Co., Firm Registration No. 318086E, with Utsav Saraf as the signing partner. The company's scrip codes are 533259 at BSE and SASTASUNDR at NSE.

Historical Stock Returns for Sastasundar Ventures

1 Day5 Days1 Month6 Months1 Year5 Years
-0.17%-0.39%-3.00%-11.51%+4.52%+56.55%

How will the rebranding to Health X Platform Limited impact the company's market positioning against established healthcare technology competitors?

What strategic acquisitions or partnerships might the company pursue to further strengthen its healthcare platform capabilities?

Will the company divest its remaining 1.76% financial services business to achieve complete focus on healthcare operations?

Health X Platform Limited Receives SEBI Compliance Certificate for Q4 FY26

1 min read     Updated on 06 Apr 2026, 07:29 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Health X Platform Limited has received its Q4 FY26 compliance certificate under SEBI Regulation 74(5) from registrar MUFG Intime India Private Limited. The certificate confirms proper handling of dematerialisation processes during the quarter ended March 31, 2026, with all securities processed within prescribed timelines and regulatory requirements met.

powered bylight_fuzz_icon
37029590

*this image is generated using AI for illustrative purposes only.

Health X Platform Limited has received its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The certificate demonstrates the company's adherence to regulatory requirements for dematerialisation processes during Q4 FY26.

Regulatory Compliance Certificate

The certificate was issued by MUFG Intime India Private Limited (formerly Link Intime India Private Limited), which serves as the registrar and share transfer agent for Health X Platform Limited. The compliance document was dated April 2, 2026, and subsequently filed with stock exchanges on April 6, 2026.

Parameter: Details
Regulation: SEBI Regulation 74(5)
Quarter Ended: March 31, 2026
Certificate Date: April 2, 2026
Filing Date: April 6, 2026
Registrar: MUFG Intime India Private Limited

Dematerialisation Process Confirmation

MUFG Intime India confirmed that all securities received from depository participants for dematerialisation during Q4 FY26 were properly processed within prescribed timelines. The registrar verified that security certificates received for dematerialisation were confirmed or rejected appropriately, with physical certificates being mutilated and cancelled after due verification.

The confirmation also states that depositories' names have been substituted in the register of members as registered owners within the mandated timeframes, ensuring compliance with SEBI regulations.

Company Information

Health X Platform Limited, formerly known as Sastasundar Ventures Limited, operates under CIN L65993WB1989PLC047002. The company is listed on both BSE (Scrip Code: 533259) and NSE (Symbol: SASTASUNDR) with ISIN INE019J01013.

Exchange Details: Information
BSE Scrip Code: 533259
NSE Symbol: SASTASUNDR
ISIN: INE019J01013
Registered Office: Kolkata

The quarterly compliance certificate filing reflects the company's ongoing commitment to maintaining regulatory standards and transparency in its share transfer and dematerialisation processes. This routine regulatory filing ensures continued compliance with SEBI depositories regulations.

Historical Stock Returns for Sastasundar Ventures

1 Day5 Days1 Month6 Months1 Year5 Years
-0.17%-0.39%-3.00%-11.51%+4.52%+56.55%

Will Health X Platform's recent name change from Sastasundar Ventures signal a strategic pivot toward digital health services in FY27?

How might SEBI's evolving depositories regulations impact Health X Platform's compliance costs and operational efficiency going forward?

Could Health X Platform's consistent regulatory compliance position it favorably for institutional investor interest in the healthcare technology sector?

More News on Sastasundar Ventures

1 Year Returns:+4.52%